Sunshine Biopharma COO Dr. Abderrazzak Merzouki resigns effective immediately

Sunshine Biopharma Inc.

Dr. Abderrazzak Merzouki resigned as COO of Sunshine Biopharma on February 5, 2026, effective immediately.
No replacement or interim COO has been announced in the filing.
The resignation is reported under Item 5.02 with no stated reason for departure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.